Author Correction: Integrating oncolytic viruses in combination cancer immunotherapy

被引：0
作者：
Praveen K. Bommareddy
Megha Shettigar
Howard L. Kaufman
机构：
[1] Rutgers Graduate School of Biomedical Sciences,
[2] Dana- Farber Cancer Institute,undefined
[3] Replimune,undefined
[4] Inc,undefined
[5] Massachusetts General Hospital,undefined
来源：
Nature Reviews Immunology | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In the initially published version of this article online in advance of print, a reference (Ajina, A. & Maher, J. Prospects for combined use of oncolytic viruses and CAR T-cells. J. Immunother. Cancer 5, 90 (2017)) was omitted in error from the following sentence: “The ability of oncolytic viruses to increase the expression of MHC class I molecules by cancer cells is also predicted to enhance ACT with TILs or TCR-engineered and chimeric antigen receptor (CAR) T cells that target tumour-specific antigens”. This has been corrected in the HTML and PDF versions of the manuscript.
引用
收藏
页码：536 / 536
相关论文
共 50 条
[21]   The discovery and development of oncolytic viruses: are they the future of cancer immunotherapy? [J].
Zhang, Shunchuan ;
Rabkin, Samuel D. .
EXPERT OPINION ON DRUG DISCOVERY, 2021, 16 (04) :391-410
[22]   Engineering strategies to enhance oncolytic viruses in cancer immunotherapy [J].
Tian, Yaomei ;
Xie, Daoyuan ;
Yang, Li .
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
[23]   Engineering strategies to enhance oncolytic viruses in cancer immunotherapy [J].
Yaomei Tian ;
Daoyuan Xie ;
Li Yang .
Signal Transduction and Targeted Therapy, 7
[24]   Strategies for engineering oncolytic viruses to enhance cancer immunotherapy [J].
Yin, Ziyang ;
Wang, Zhengfeng .
FRONTIERS IN PHARMACOLOGY, 2024, 15
[25]   Breast cancer immunotherapy using magnetised oncolytic viruses [J].
AL-Janabi, H. ;
Conner, J. ;
Taher, Z. ;
Staniland, S. ;
Muthana, M. .
EUROPEAN JOURNAL OF CANCER, 2018, 92 :S4-S4
[26]   Comprehensive assessment on the applications of oncolytic viruses for cancer immunotherapy [J].
Omole, Richard Kolade ;
Oluwatola, Oluwaseyi ;
Akere, Millicent Tambari ;
Eniafe, Joseph ;
Agboluaje, Elizabeth Oladoyin ;
Daramola, Oluwafemi Bamidele ;
Ayantunji, Yemisi Juliet ;
Omotade, Temiloluwa Ifeoluwa ;
Torimiro, Nkem ;
Ayilara, Modupe Stella ;
Adeyemi, Oluwole Isaac ;
Salinsile, Olubusola Sajanat .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[27]   Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses [J].
Goradel, Nasser Hashemi ;
Alizadeh, Arezoo ;
Hosseinzadeh, Shahnaz ;
Taghipour, Mitra ;
Ghesmati, Zeinab ;
Arashkia, Arash ;
Negahdari, Babak .
FUTURE ONCOLOGY, 2021, 18 (02) :245-259
[28]   Fusogenic Viruses in Oncolytic Immunotherapy [J].
Krabbe, Teresa ;
Altomonte, Jennifer .
CANCERS, 2018, 10 (07)
[29]   Combination therapy with oncolytic viruses for lung cancer treatment [J].
Sun, Lei ;
Zhao, Qi ;
Miao, Liyun .
FRONTIERS IN ONCOLOGY, 2025, 15
[30]   Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer [J].
Omid Hamid ;
Brianna Hoffner ;
Eduard Gasal ;
Jenny Hong ;
Richard D. Carvajal .
Cancer Immunology, Immunotherapy, 2017, 66 :1249-1264
12345